Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency.

Geier, Christoph B; Farmer, Jocelyn R; Foldvari, Zsofia; Ujhazi, Boglarka; Steininger, Jolanda; Sleasman, John W; Parikh, Suhag; Dilley, Meredith A; Pai, Sung-Yun; Henderson, Lauren; Hazen, Melissa; Neven, Benedicte; Moshous, Despina; Sharapova, Svetlana O; Mihailova, Snezhina; Yankova, Petya; Naumova, Elisaveta; Özen, Seza; Byram, Kevin; Fernandez, James; Wolf, Hermann M; Eibl, Martha M; Notarangelo, Luigi D; Calabrese, Leonard H; Walter, Jolan E

Geier, Christoph B; Farmer, Jocelyn R; Foldvari, Zsofia; Ujhazi, Boglarka; Steininger, Jolanda; Sleasman, John W; Parikh, Suhag; Dilley, Meredith A; Pai, Sung-Yun; Henderson, Lauren; Hazen, Melissa; Neven, Benedicte; Moshous, Despina; Sharapova, Svetlana O; Mihailova, Snezhina; Yankova, Petya; Naumova, Elisaveta; Özen, Seza; Byram, Kevin; Fernandez, James; Wolf, Hermann M; Eibl, Martha M; Notarangelo, Luigi D; Calabrese, Leonard H; Walter, Jolan E.

Afiliación

Geier CB; Immunology Outpatient Clinic, Vienna, Austria.
Farmer JR; Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States.
Foldvari Z; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.
Ujhazi B; University of South Florida and Johns Hopkins All Children's Hospital, Saint Petersburg, FL, United States.
Steininger J; Immunology Outpatient Clinic, Vienna, Austria.
Sleasman JW; Division of Allergy, Immunology and Pulmonary Medicine, Duke University School of Medicine, Durham, NC, United States.
Parikh S; Emory University School of Medicine, Atlanta, GA, United States.
Dilley MA; Department of Immunology, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States.
Pai SY; Division of Hematology-Oncology, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States.
Henderson L; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
Hazen M; Harvard Medical School, Boston, MA, United States.
Neven B; Division of Immunology, Department of Rheumatology, Boston Children's Hospital, Boston, MA, United States.
Moshous D; Division of Immunology, Department of Rheumatology, Boston Children's Hospital, Boston, MA, United States.
Sharapova SO; Imagine Institute, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Mihailova S; Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Yankova P; Laboratory "Immunogenetics of Pediatric autoimmune diseases", INSERM UMR1163, Institut Imagine, Université Paris Descartes Sorbonne Paris Cité, Paris, France.
Naumova E; Imagine Institute, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Özen S; Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Byram K; Laboratory of Genome Dynamics in The Immune System, Paris, France.
Fernandez J; Research Department, Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
Wolf HM; Department of Clinical Immunology Medical University of Sofia, Sofia, Bulgaria.
Eibl MM; Department of Clinical Immunology Medical University of Sofia, Sofia, Bulgaria.
Notarangelo LD; Department of Clinical Immunology Medical University of Sofia, Sofia, Bulgaria.
Calabrese LH; Division of Rheumatology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Walter JE; Cleveland Clinic Center for Vasculitis Care and Research, Cleveland, OH, United States.

Front Immunol ; 11: 574738, 2020.

Article en En | MEDLINE | ID: mdl-33193364

Asunto(s)

Proteínas de Unión al ADN/genética; Proteínas de Homeodominio/genética; Proteínas Nucleares/genética; Inmunodeficiencia Combinada Grave/inmunología; Vasculitis/inmunología; Adolescente; Adulto; Autoanticuerpos/sangre; Biomarcadores/sangre; Niño; Preescolar; Proteínas de Unión al ADN/deficiencia; Bases de Datos Factuales; Femenino; Predisposición Genética a la Enfermedad; Humanos; Lactante; Interferón Tipo I/inmunología; Interferón-alfa/inmunología; Interleucina-12/inmunología; Masculino; Persona de Mediana Edad; Proteínas Nucleares/deficiencia; Fenotipo; Prevalencia; Pronóstico; Inmunodeficiencia Combinada Grave/epidemiología; Inmunodeficiencia Combinada Grave/genética; Inmunodeficiencia Combinada Grave/terapia; Vasculitis/epidemiología; Vasculitis/terapia; Adulto Joven

Palabras clave

atypical SCID; autoimmunity; combined immunodeficiency with granuloma and/or autoimmunity; primary immumunodeficiencies; rag deficiency; severe combined immunodeficiencies (SCID); vasculitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de salud: 2_muertes_prevenibles / 6_cardiovascular_diseases / 6_endocrine_disorders / 7_neonatal_care_health / 7_non_communicable_diseases Asunto principal: Vasculitis / Proteínas Nucleares / Inmunodeficiencia Combinada Grave / Proteínas de Homeodominio / Proteínas de Unión al ADN Tipo de estudio: Clinical_trials / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Austria

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google